Latest news with #financialstatement
Zawya
6 days ago
- Business
- Zawya
Egypt: SODIC posts 107.5% YoY consolidated profit in H1 2025
Egypt - Sixth of October Development and Investment Company (SODIC) reported a 107.48% year-on-year (YoY) surge in consolidated net profits attributable to the parent company during the first half (H1) of 2025 to EGP 1.297 billion from EGP 625.535 million, according to financial statement. Total operating revenues soared to EGP 4.779 billion in H1 2025 from EGP 3.935 billion in H1 2023. On the other hand, the firm's standalone net profits after tax soared to EGP 390.101 million in the six-month period, versus EGP 45.885 million over the same period a year ago. Meanwhile, standalone operating revenues declined to EGP 2.171 billion from EGP 1.486 billion. Established in 1996, SODIC is a mixed-use developer listed on the EGX, with a portfolio of diversified projects across Egypt, particularly in Cairo and the North Coast. © 2020-2023 Arab Finance For Information Technology. All Rights Reserved. Provided by SyndiGate Media Inc. (
Bloomberg
28-05-2025
- Business
- Bloomberg
BOJ's Bond Holding Paper Losses Hit Record After Rate Hikes
The Bank of Japan amassed the largest amount of unrealized losses on record from its government bond holdings in the year ended March, highlighting the challenges it faces in unwinding more than a decade of extraordinary monetary easing. The paper losses from government bonds tripled from the previous year to ¥28.6 trillion ($198 billion) at the end of the fiscal year 2024, according to the central bank's financial statement released Wednesday.
Zawya
26-05-2025
- Business
- Zawya
Egypt: Arab Drug Company's profits grow 99.6% YoY in 9 months
Arab Finance: Arab Drug Company's (ADCI) net profits after tax jumped 99.59% year on year (YoY) in the first nine months of the fiscal year (FY) 2024/2025, according to the company's financial statement. Net profits after tax recorded EGP 164.674 million from July to March of the current FY, up from EGP 82.504 million in the same period of the previous FY. Meanwhile, total operating revenues grew to EGP 819.145 million from EGP 581.211 million. Arab Drug is an Egypt-based company engaged in the pharmaceutical sector. The company focuses on the manufacture, packaging, and distribution of pharmaceutical products as well as chemical solutions for human and veterinary use. © 2020-2023 Arab Finance For Information Technology. All Rights Reserved. Provided by SyndiGate Media Inc. (
